Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04176848 |
| Title | CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer |
| Recruitment | Unknown status |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Canadian Cancer Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| BCCA - Cancer Centre for the Southern Interior | Kelowna | British Columbia | V1Y 5L3 | Canada | Details | |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| Kingston Health Sciences Centre | Kingston | Ontario | K7L 2V7 | Canada | Details | |
| Ottawa Hospital Research Institute | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| University Health Network | Toronto | Ontario | M5G 2M9 | Canada | Details |